Is SANUWAVE Health, Inc. Common Stock (SNWV) overvalued? · P/E 9.5, rev $32.6M
SANUWAVE Health, Inc. Common Stock (SNWV) is a medical devices company listed on NASDAQ.
This page asks whether SANUWAVE Health, Inc. Common Stock (SNWV) looks expensive on cached numbers — not a short thesis.
Latest reported SNWV revenue for 2024-12-31 was $32.6M. Net income was -$31.4M. Revenue was up 60.0% from 2023-12-31 to 2024-12-31. SNWV currently screens at market cap $78.2M and trailing P/E 9.5.
SNWV currently screens at market cap $78.2M and trailing P/E 9.5. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next SNWV 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the SNWV stock page for the full model, not this heading.
Not investment advice.